MACK
Merrimack Pharmaceuticals, Inc.
MACK
MACK
Delisted
MACK was delisted on the 17th of May, 2024.
140 hedge funds and large institutions have $467M invested in Merrimack Pharmaceuticals, Inc. in 2016 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 51 increasing their positions, 30 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
70% less call options, than puts
Call options by funds: $227K | Put options by funds: $754K
Holders
140
Holding in Top 10
1
Calls
$227K
Puts
$754K
Top Buyers
| 1 | +$11M | |
| 2 | +$9.43M | |
| 3 | +$7M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$5.16M |
| 5 |
Westfield Capital Management
Boston,
Massachusetts
|
+$5.11M |
Top Sellers
| 1 | -$49.2M | |
| 2 | -$5.23M | |
| 3 | -$2.93M | |
| 4 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
-$2.05M |
| 5 |
VOYA Investment Management
Atlanta,
Georgia
|
-$2.01M |